COMMUNIQUÉS West-GlobeNewswire

Ultragenyx Announces Positive 24-week Data from First Cohort of Phase 1/2 Study of DTX401 Gene Therapy in Glycogen Storage Disease Type Ia

21/02/2019 - 14:30

DTX401 Response in Time to Hypoglycemia and Improved Glucose Control Maintained or Improved in All Three Patients Data from Higher-dose Cohort 2 Expected Mid-2019 NOVATO, Calif., Feb. 21, 2019 (GLOBE NEWSWIRE) -- [...]

Ziopharm Oncology CEO to Present at the CAR-TCR Summit Europe

21/02/2019 - 14:30

BOSTON, Feb. 21, 2019 (GLOBE NEWSWIRE) -- Ziopharm Oncology , Inc. (Nasdaq:ZIOP) today announced that Chief Executive Officer Laurence Cooper, M.D., Ph.D, is scheduled to present and participate in a panel discussion on [...]

With a Strategic Investment by Aleafia Health, Aura Health Announces Increase to Previously Announced Brokered Subscription Receipt Financing to $7.26 Million

21/02/2019 - 14:19

NOT FOR DISTRIBUTION TO UNITED STATES NEWSWIRE SERVICES OR FOR RELEASE, PUBLICATION, DISTRIBUTION OR DISSEMINATION DIRECTLY, OR INDIRECTLY, IN WHOLE OR IN PART, IN OR INTO THE UNITED STATES. TORONTO, Feb. 21, 2019 ( [...]

Aduro Biotech to Present at the 8th Annual SVB Leerink Global Healthcare Conference

21/02/2019 - 14:15

BERKELEY, Calif., Feb. 21, 2019 (GLOBE NEWSWIRE) -- Aduro Biotech, Inc. (NASDAQ: ADRO) today announced that Stephen T. Isaacs, chairman, president and chief executive officer of Aduro, is scheduled to present at the 8 [...]

Cognition Therapeutics Receives European Patent Covering its Alzheimer's Disease Candidate, Elayta™

21/02/2019 - 14:03

Pittsburgh, Feb. 21, 2019 (GLOBE NEWSWIRE) -- Cognition Therapeutics, Inc. , a clinical stage neuroscience company focused on the protection and restoration of synaptic function in neurodegenerative diseases and [...]

Genocea to Host Quarterly Corporate Update Conference Call & Webcast on February 28 at 9:00 am ET

21/02/2019 - 14:00

CAMBRIDGE, Mass., Feb. 21, 2019 (GLOBE NEWSWIRE) -- Genocea Biosciences, Inc. (NASDAQ: GNCA), a biopharmaceutical company developing personalized cancer immunotherapies, today announced that it will host a conference [...]

HTG Molecular to Present Corporate Overview at the Cowen & Company 39th Annual Health Care Conference

21/02/2019 - 14:00

TUCSON, Ariz., Feb. 21, 2019 (GLOBE NEWSWIRE) -- HTG Molecular Diagnostics , Inc. (Nasdaq: HTGM) (HTG), a life science company whose mission is to advance precision medicine, today announced that TJ Johnson, Chief [...]

Zogenix to Release Fourth Quarter and Full-Year 2018 Financial Results and Host Conference Call and Webcast on February 28

21/02/2019 - 14:00

EMERYVILLE, Calif., Feb. 21, 2019 (GLOBE NEWSWIRE) -- Zogenix, Inc. (NASDAQ: ZGNX), a global pharmaceutical company developing rare disease therapies, today announced that it will report its financial results for the [...]

GBT Announces Participation at the 8th Annual SVB Leerink Global Healthcare Conference

21/02/2019 - 14:00

SOUTH SAN FRANCISCO, Calif., Feb. 21, 2019 (GLOBE NEWSWIRE) -- Global Blood Therapeutics, Inc. (GBT) (NASDAQ: GBT) today announced that it will present at the 8th Annual SVB Leerink Global Healthcare Conference in New [...]

Chiesi Joins National Organization for Rare Disorders (NORD)® Corporate Council

21/02/2019 - 14:00

Partnership supports Chiesi USA presence in global rare disease market CARY, N.C., Feb. 21, 2019 (GLOBE NEWSWIRE) -- Chiesi USA (key-A-zee), a specialty pharmaceutical company, and the National Organization for Rare [...]

Intra-Cellular Therapies to Present at the 8th Annual SVB Leerink Global Healthcare Conference

21/02/2019 - 14:00

NEW YORK, Feb. 21, 2019 (GLOBE NEWSWIRE) -- Intra-Cellular Therapies, Inc. (Nasdaq:ITCI), a biopharmaceutical company focused on the development of therapeutics for central nervous system (CNS) disorders, today [...]

Achaogen Announces Publication of Plazomicin Phase 3 CARE Study Results in the New England Journal of Medicine

21/02/2019 - 14:00

SOUTH SAN FRANCISCO, Calif., Feb. 21, 2019 (GLOBE NEWSWIRE) -- Achaogen, Inc. (Nasdaq: AKAO), a biopharmaceutical company discovering, developing and commercializing innovative antibacterial agents to address multi-drug [...]

Axovant to Host First R&D Day March 29, 2019

21/02/2019 - 14:00

NEW YORK and BASEL, Switzerland, Feb. 21, 2019 (GLOBE NEWSWIRE) -- Axovant Sciences (NASDAQ: AXGT), a clinical-stage company developing innovative gene therapies, today announced that it will host its first R&D Day [...]

AlloSure now available for Lung Transplant Patients

21/02/2019 - 14:00

New data highlights the value of AlloSure to detect rejection in one of the most complex transplanted organs BRISBANE, Calif., Feb. 21, 2019 (GLOBE NEWSWIRE) -- CareDx, Inc. (Nasdaq: CDNA), a molecular diagnostics [...]

Sienna Announces 2019 Annual and Special Meeting

21/02/2019 - 19:39

MARKHAM, Ontario, Feb. 21, 2019 (GLOBE NEWSWIRE) -- Sienna Senior Living Inc. (" Sienna " or the " Company ") (TSX: SIA) today announced that it will be hosting its 2019 annual and special meeting of shareholders on [...]

Bavarian Nordic Announces Initiation of Phase 1/2a Clinical Trial of Therapeutic HPV Vaccine Regimen in Collaboration with Janssen

21/02/2019 - 19:34

First commercial program under Bavarian Nordic and Janssen Vaccines & Prevention B.V. collaboration advancing into clinical trials A therapeutic vaccine may represent a novel approach for early treatment and [...]

Melinta Therapeutics Announces One-for-Five Reverse Stock Split

21/02/2019 - 19:30

NEW HAVEN, Conn., Feb. 21, 2019 (GLOBE NEWSWIRE) -- Melinta Therapeutics, Inc. (NASDAQ: MLNT), a commercial-stage company focused on the development and commercialization of novel antibiotics to treat serious bacterial [...]

SuperSonic Imagine will present its Aixplorer® MACH 30 ultrasound system at the 25th European Congress of Radiology (ECR 2019)

21/02/2019 - 19:23

in Vienna, Austria, from 27 February to 3 March 2019 AIX-EN-PROVENCE, France, Feb. 21, 2019 (GLOBE NEWSWIRE) -- SuperSonic Imagine (Euronext: SSI, FR0010526814, PEA-PME eligible), a company specialising in ultrasound [...]

SuperSonic Imagine présentera son échographe Aixplorer® MACH 30 lors de la 25ème édition du Congrès Européen de Radiologie (ECR) 2019

21/02/2019 - 19:23

à Vienne en Autriche du 27 février au 3 mars 2019 AIX-EN-PROVENCE, France, 21 févr. 2019 (GLOBE NEWSWIRE) -- SuperSonic Imagine (Euronext: SSI, FR0010526814, éligible PEA-PME), société spécialisée dans l’imagerie [...]